These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9380726)

  • 1. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.
    Gately S; Twardowski P; Stack MS; Cundiff DL; Grella D; Castellino FJ; Enghild J; Kwaan HC; Lee F; Kramer RA; Volpert O; Bouck N; Soff GA
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10868-72. PubMed ID: 9380726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.
    Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA
    Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 inhibits generation of angiostatin by human pancreatic cancer cells.
    O'Mahony CA; Albo D; Tuszynski GP; Berger DH
    Surgery; 1998 Aug; 124(2):388-93. PubMed ID: 9706163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.
    Westphal JR; Van't Hullenaar R; Geurts-Moespot A; Sweep FC; Verheijen JH; Bussemakers MM; Askaa J; Clemmensen I; Eggermont AA; Ruiter DJ; De Waal RM
    Int J Cancer; 2000 Jun; 86(6):760-7. PubMed ID: 10842188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiostatin generation by human pancreatic cancer.
    O'Mahony CA; Seidel A; Albo D; Chang H; Tuszynski GP; Berger DH
    J Surg Res; 1998 Jun; 77(1):55-8. PubMed ID: 9698533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.
    Binda MM; Matar P; González AD; Rozados VR; Gervasoni SI; Scharovsky OG; Bonfil RD
    Int J Cancer; 2002 Jul; 100(1):14-21. PubMed ID: 12115581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model.
    de Groot-Besseling RR; Ruers TJ; van Kraats AA; Poelen GJ; Ruiter DJ; de Waal RM; Westphal JR
    Int J Cancer; 2004 Nov; 112(2):329-34. PubMed ID: 15352048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.
    de Groot-Besseling RR; Ruers TJ; Lamers-Elemans IL; Maass CN; de Waal RM; Westphal JR
    BMC Cancer; 2006 Jun; 6():149. PubMed ID: 16753063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance.
    O'Reilly MS; Wiederschain D; Stetler-Stevenson WG; Folkman J; Moses MA
    J Biol Chem; 1999 Oct; 274(41):29568-71. PubMed ID: 10506224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
    Merchan JR; Chan B; Kale S; Schnipper LE; Sukhatme VP
    J Natl Cancer Inst; 2003 Mar; 95(5):388-99. PubMed ID: 12618504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.
    O'Reilly MS; Holmgren L; Shing Y; Chen C; Rosenthal RA; Moses M; Lane WS; Cao Y; Sage EH; Folkman J
    Cell; 1994 Oct; 79(2):315-28. PubMed ID: 7525077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accumulation of angiostatin-like fragments in human prostate carcinoma.
    Migita T; Oda Y; Naito S; Morikawa W; Kuwano M; Tsuneyoshi M
    Clin Cancer Res; 2001 Sep; 7(9):2750-6. PubMed ID: 11555588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells.
    Morikawa W; Yamamoto K; Ishikawa S; Takemoto S; Ono M; Fukushi Ji; Naito S; Nozaki C; Iwanaga S; Kuwano M
    J Biol Chem; 2000 Dec; 275(49):38912-20. PubMed ID: 10986284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
    Cornelius LA; Nehring LC; Harding E; Bolanowski M; Welgus HG; Kobayashi DK; Pierce RA; Shapiro SD
    J Immunol; 1998 Dec; 161(12):6845-52. PubMed ID: 9862716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor production of angiostatin is enhanced after exposure to TNF-alpha.
    Mauceri HJ; Seetharam S; Beckett MA; Lee JY; Gupta VK; Gately S; Stack MS; Brown CK; Swedberg K; Kufe DW; Weichselbaum RR
    Int J Cancer; 2002 Feb; 97(4):410-5. PubMed ID: 11802200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid follicular cells secrete plasminogen activators and can form angiostatin from plasminogen.
    Ramsden JD; Yarram S; Mathews E; Watkinson JC; Eggo MC
    J Endocrinol; 2002 Jun; 173(3):475-81. PubMed ID: 12065237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.